Vascular endothelial growth factor expression and secretion by retinal pigment epithelial cells in high glucose and hypoxia is protein kinase C-dependent

https://doi.org/10.1016/j.exer.2004.11.015Get rights and content

Abstract

Retinal pigment epithelial (RPE) cells express vascular endothelial growth factor (VEGF) in response to high glucose or hypoxia. We hypothesised that VEGF expression and secretion by RPE cells in high glucose and hypoxia are regulated by protein kinase C (PKC). Primary cultured RPE cells from Sprague–Dawley rats were growth-arrested for 48 hr in 0.5% FBS in 5.6 or 30 mm d-glucose. Cells were exposed to hypoxic conditions (<1% O2, 5% CO2) for the last 15–18 hr of growth-arrest. PKC -α, -β1, -δ, -ε, and -ζ were expressed by RPE cells and exposure to high glucose for 48 hr had no effect on expression as demonstrated by Western immunoblotting. High glucose, hypoxia or VEGF stimulated translocation of a number of the PKC isozymes to the membrane or particulate fractions implying activation. In response to high glucose or acute phorbol myristate acetate (PMA) stimulation, VEGF mRNA analysed by RT-PCR was increased. Intracellular VEGF protein identified by immunoblotting and confocal immunofluorescence imaging was significantly increased by high glucose, hypoxia or acute PMA stimulation. Calphostin C or a specific inhibitor of PKC-ζ prevented high glucose-stimulated VEGF expression in high glucose. VEGF secretion, as measured by ELISA in the culture medium, was enhanced in hypoxia but not in high glucose. Following exposure of RPE cells to PMA for 24 hr, PKC-δ was significantly down regulated, whereas PKC-α, -β, -ε and -ζ remained unchanged. Secretion of VEGF in normal or high glucose, or hypoxia was significantly reduced following treatment with PMA for 24 hr but not with the PKC-ζ inhibitor. We conclude that in high glucose and hypoxia PKC isozymes are activated and are necessary for VEGF expression. Secretion of VEGF is enhanced in hypoxia and appears to be regulated by PKC-δ. RPE cells may contribute to the pathogenesis of retinopathy caused by high glucose and hypoxia through the expression and secretion of VEGF that are regulated by PKC isozymes.

Introduction

Retinal pigment epithelial (RPE) cells, situated between the neurosensory retina and the choroid, form the outer blood retinal barrier and are essential for the nutritional and metabolic support of the photoreceptors. Among the growth factors produced and secreted by RPE cells, vascular endothelial growth factor (VEGF) is expressed in response to mechanical stretch (Seko et al., 1999), hypoxia (Mousa et al., 1999) and high glucose (Sone et al., 1996). VEGF receptors are expressed on the RPE cell surface likely indicating important homeostatic and autocoid regulation (Kociok et al., 1998). VEGF is a potent endothelial cell mitogen and permeability factor contributing to angiogenesis (Aiello et al., 1997, Aiello et al., 1994). RPE cells may contribute to the pathogenesis of diabetic retinopathy through their production of VEGF.

Hyperglycemia initiates a cascade of target cell signaling responses and consequent cellular dsyfunction that result in ocular, renal, cardiovascular and other end-organ damage associated with diabetes mellitus (Mooradian and Thurman, 1999). Retinal capillary damage from high glucose-induced pericyte loss (Kern and Engerman, 1996, Agardh et al., 1997) and alterations in retinal hemodynamics (Bursell et al., 1997, Grunwald et al., 1995, Kunisaki et al., 1998) cause a hypoxic state in both the early and late stages of diabetic retinopathy. In retinal endothelial cells and pericytes, high glucose causes activation of protein kinase C (PKC) and consequent expression of VEGF (Enaida et al., 1999, Hata et al., 1999). Exposure to hypoxia and advanced-glycation end products causes additive VEGF expression by RPE cells (Lu et al., 1998). The PKC-dependency of VEGF expression has been shown in several cell types, including mesangial (Cha et al., 2000), vascular smooth muscle (Williams et al., 1997), vascular endothelial cells (Xia et al., 1996) and retinal endothelial cells (Ishii et al., 1998). Hypoxia mediates VEGF expression by increased binding of the active hypoxia inducible factor (HIF)-1α to the hypoxic response element of the VEGF promoter and by increasing the stability of the VEGF mRNA transcript through mitogen-activated protein kinase and Akt pathways, respectively (Suzuma et al., 2000). Hypoxia is the strongest stimulus of VEGF expression and it is likely that the signaling effects of hyperglycemia and hypoxia contribute to the progression of diabetic retinopathy. VEGF activates several PKC isozymes through stimulation of its tyrosine kinase receptor and the phospholipase Cγ pathway in aortic endothelial cells (Xia et al., 1996). The mechanisms by which these effects may regulate VEGF expression and secretion in the RPE cell type remain incompletely understood.

In this study, we hypothesised that high glucose, hypoxia and VEGF would activate specific PKC isozymes in primary cultured RPE cells. Furthermore, we postulated that high glucose and hypoxia-induced production and secretion of VEGF in RPE cells may be PKC dependent. PKC isozyme translocation/activation patterns in response to VEGF and hypoxia, with or without high glucose, were analysed by Western immunoblotting of subcellular fractions and confocal immunofluorescence imaging. Diacylglycerol (DAG)-sensitive PKC isozymes were acutely stimulated by phorbol myristate acetate (PMA) and all PKC isozymes were inhibited with Calphostin C. PKC-δ was selectively down regulated following 24 hr exposure to PMA compared to the other DAG-sensitive PKC isozymes that required 48 hr for down regulation, and PKC-ζ function was blocked using a specific cell-permeable peptide inhibitor. VEGF transcription, translation and secretion into the culture medium were measured. We found that high glucose, hypoxia and VEGF stimulated specific DAG-sensitive PKC isozymes. VEGF expression appears to be dependent on PKC isozymes including PKC-ζ and secretion appears to require PKC-δ.

Section snippets

Materials

Dulbecco's modified Eagle medium (DMEM), Penicillin, Streptomycin, fetal bovine serum (FBS), EDTA were purchased from Life Technologies (Burlington, Ontario). Antibodies used were as follows: polyclonal anti-pan-cytokeratin antibody and affinity-purified polyclonal anti-PKC-α, -δ, -ε, -γ, and -ζ from Sigma Chemicals (St Louis, MO); anti-PKC-β1, -β2 and anti-VEGF from Santa Cruz Biotechnology (Santa Cruz, CA); horse-radish peroxidase-conjugated anti-rabbit IgG from BioRad (Hercules, CA); and

Expression of PKC isozymes and response to PMA

Fig. 1 illustrates the immunoblotting of PKC-α, -β1, -δ, -ε, and -ζ content of total cell lysate of primary RPE cells and the differential response of the DAG-sensitive PKC isozymes to PMA 100 nm exposure for 24 hr and 48 hr. At 24 hr only PKC-δ was down regulated, whereas following 48 hr all the DAG-sensitive PKC isozymes were down regulated. As expected DAG-insensitive PKC-ζ was unaffected by PMA. As observed in Fig. 2, in the presence of PMA 100 nm for 10 min, PKC-α, -β1, -δ, and -ε, but not PKC-ζ,

Discussion

We report that PKC-α, -β1, -δ, -ε, and -ζ but not PKC-β2 are expressed under basal conditions by primary cultured rat RPE cells. The DAG-sensitive PKC -α, -β1, -δ, and -ε responded to PMA stimulation by translocating to membrane or particulate cellular fractions. Differential down regulation of DAG-sensitive PKC isozymes was observed at 24 and 48 hr. Exposure to high glucose for 48 hr had no significant effect on the expression of PKC isozymes in RPE cells as detected by Western immunoblotting.

Acknowledgements

This research was funded by a grant from the Canadian Diabetes Association and the Banting and Best Diabetes Center, University of Toronto. Dr T. Young was supported by a postdoctoral fellowship from the Canadian Diabetes Association (Harry Myers Grant), the fellowship program from the Vision Sciences Research Program and the Banting and Best Diabetes Center, University of Toronto.

References (41)

  • L.P. Aiello et al.

    Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor

    Diabetes

    (1997)
  • E. Berra et al.

    MAP kinases and hypoxia in the control of VEGF expression

    Cancer Metastasis Rev.

    (2000)
  • Z.M. Bian et al.

    Glycated serum albumin induces chemokine gene expression in human retinal pigment epithelial cells

    J. Leukoc. Biol.

    (1996)
  • S.E. Brooks et al.

    Modulation of VEGF production by pH and glucose in retinal Muller cells

    Curr. Eye Res.

    (1998)
  • S.E. Bursell et al.

    Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats

    Invest. Ophthalmol. Vis. Sci.

    (1997)
  • J.A. Dlugosz et al.

    Endothelin-1-induced mesangial cell contraction involves activation of protein kinase C- alpha, -delta, and -epsilon

    Am. J. Physiol.

    (1998)
  • J.A. Dlugosz et al.

    Mesangial cell filamentous actin disassembly and hypocontractility in high glucose are mediated by PKC-zeta

    Am. J. Physiol.

    (2002)
  • W. Eichler et al.

    VEGF release by retinal glia depends on both oxygen and glucose supply

    Neuroreport

    (2000)
  • H. Enaida et al.

    VEGF-dependent signaling in retinal microvascular endothelial cells Fukushima

    J. Med. Sci.

    (1999)
  • M. Goldberg et al.

    Hypoxia alters the subcellular distribution of protein kinase C isoforms in neonatal rat ventricular myocytes

    J. Clin. Invest.

    (1997)
  • Cited by (48)

    • Astaxanthin mediated regulation of VEGF through HIF1α and XBP1 signaling pathway: An insight from ARPE-19 cell and streptozotocin mediated diabetic rat model

      2021, Experimental Eye Research
      Citation Excerpt :

      The levels of VEGF were augmented in the retinal cells, aqueous humour and vitreous fluid of patients with DR (Adamis et al., 1994; Pe'er et al., 1996); dysregulation in VEGF secretion is associated with the increased risk of progressive diabetic retinopathy (Boulton et al., 1998; Funatsu et al, 2005, 2006; Simó and Hernández, 2008). Studies revealed that under hyperglycemic conditions, the mRNA and protein levels of VEGF is upregulated in RPE cells (Young et al., 2005). Though the role of RPE-derived VEGF in retinal angiogenesis has not been understood completely, the genetic disruption of RPE-derived VEGF in diabetic mice has shown to reduce the diabetes-induced vascular leakage and inflammation (Xu et al., 2011).

    • The PKC-ζ pseudosubstrate peptide induces glutamate release from retinal pigment epithelium cells through kinase- independent activation of Best1

      2021, Life Sciences
      Citation Excerpt :

      Thrombin is considered an inflammatory factor that activates specific cellular receptors [14] that elevate intracellular Ca2+ by phospholipase C-β (PLC-β) and protein kinase C (PKC), as well as by the reverse activity of the Na+/Ca2+ exchanger in RPE cells [4]. In this line, PKC signaling pathways, particularly those activated by the atypical isozyme PKCζ, have been involved in the stimulation of proliferation and migration of RPE cells [15]; as well as influence gene expression and chemokine release [15,16]. Hereby we analyzed the role of PKCζ in RPE glutamate release using a pseudosubstrate peptide (PKC ζ PS) commonly used to inhibit this enzyme.

    • Retinal pigment epithelium-secretome: A diabetic retinopathy perspective

      2017, Cytokine
      Citation Excerpt :

      Moreover, dysregulation/imbalance in VEGF secretion has correlated with the severity of PDR [5,54]. Concurrently, in vitro studies of RPE cells cultured in high glucose conditions demonstrate upregulation of mRNA and protein levels of VEGF [55]. Studies demonstrate that in pathological conditions, VEGF causes modification of tight junction proteins such as zonular occuludin-1 alpha and transepithelial resistance [56].

    • Glycemic Index and Age-Related Macular Degeneration

      2014, Handbook of Nutrition, Diet and the Eye
    View all citing articles on Scopus
    View full text